Skip to main content
. 2021 Nov 30;1:52. doi: 10.1038/s43856-021-00053-9

Fig. 2. Comparing the clinical traits and IDU-BSI and non-IDU BSI.

Fig. 2

a Number of unique patients with S. aureus IDU-BSI and non-IDU BSI (bars), and 90-day rolling average proportion of total BSI cases that are IDU-associated (line) identified in BJH from 1/1/2016 to 12/31/2019. b Duration in days of S. aureus bacteremia among adults stratified by IDU-BSI and non-IDU BSI. c Among BSI cases, AMA discharges and prolonged bacteremia (≥5 days) was more common among IDU-BSI with lower rates of completion of standard of care intravenous (IV) antibiotics but did not translate into higher 1 year mortality rates. d Kaplan–Meier survival curves comparing S. aureus IDU-BSI and non-IDU BSI with number at risk below the graph.